logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Barbara Ann Karmanos Cancer Institute Launches TheraBionic P1 Device to Treat Advanced Liver Cancer

Dec 18, 202412 months ago
DetroitNon ProfitMedicalEducationBiotechnologyHealth Care

Product Description

The Karmanos Cancer Institute announces the availability of the TheraBionic P1, an FDA-approved, at-home treatment device for advanced liver cancer, being the first in the world to prescribe it. This innovative handheld device utilizes radiofrequency electromagnetic fields specifically targeting cancerous tumors.

Company Information

Company

Karmanos

Location

Detroit, Michigan, United States

About

Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org. Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube. SOURCE Karmanos Cancer Institute

Product Launch Insights

Based on market data
Market expansion signals
New product launches often coincide with market expansion initiatives

Related People